ArticleOpen life sciences2026
Transrectal ultrasonographic parameters combined with total serum exosomes for the assessment of bone metastases in prostate cancer.
Article in Open life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated transrectal ultrasound parameters and total serum exosome levels in prostate cancer (PCa) patients with bone metastasis (BM), and evaluated their combined value in assessing metastatic status. 40 PCa patients were categorized into non-bone metastasis (NBM, 21 cases) and BM (19 cases) groups based on single photon emission computed tomography/computed tomography or bone scans. Serum exosomes were extracted and analyzed via nanoparticle tracking analysis, while transrectal ultrasound and ultrasound-guided biopsies were performed. The study compared exosome levels and ultrasound parameters between groups, and assessed their diagnostic value for BM using receiver operating characteristic (ROC) curves, and analyzed correlations between exosomes and ultrasound findings. PCa patients with BM showed significantly higher serum exosome concentrations and ultrasound parameters (peak intensity, area under the curve (AUC), and Grad) than NBM patients (p < 0.001). ROC analysis revealed optimal cutoff values for discriminating BM: 19.33 dB for PI, 1,156.63 dB s for AUC, 2.02 dB/s for Grad, and 3.34 × E
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.